The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Effects of Schedule I drug laws on neuroscience research and treatment innovation
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Ricaurte, G. A., Yuan, J., Hatzidimitriou, G., Cord, B. J., & McCann, U. D. (2002) · Science · doi:10.1126/science.1074501 · Cited by 179
RetractedPower failure: why small sample size undermines the reliability of neuroscience
Button, K. S., Ioannidis, J. P. A., Mokrysz, C., Nosek, B. A., Flint, J., Robinson, E. S. J., & Munafò, M. R. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3475 · Cited by 7,641
Cannabinoid receptor localization in brain.
Herkenham, M., Lynn, A. B., Little, M. D., Johnson, M. R., Melvin, L. S., de Costa, B. R., & Rice, K. C. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.5.1932 · Cited by 2,321
Griffiths, R. R., Richards, W. A., McCann, U., & Jesse, R. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0457-5 · Cited by 1,684
Drug harms in the UK: a multicriteria decision analysis
Nutt, D. J., King, L. A., & Phillips, L. D. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61462-6 · Cited by 1,681
Self-citationDevelopment of a rational scale to assess the harm of drugs of potential misuse
Nutt, D., King, L. A., Saulsbury, W., & Blakemore, C. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60464-4 · Cited by 1,302
Self-citationNichols, D. E. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2003.11.002 · Cited by 1,211
Self-citationPilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer
Grob, C. S., Danforth, A. L., Chopra, G. S., Hagerty, M., McKay, C. R., Halberstadt, A. L., & Greer, G. R. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.116 · Cited by 1,206
Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin
Carhart-Harris, R. L., Erritzoe, D., Williams, T., Stone, J. M., Reed, L. J., Colasanti, A., Tyacke, R. J., Leech, R., Malizia, A. L., Murphy, K., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1119598109 · Cited by 1,172
Self-citationPsilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action
Vollenweider, F. X., Vollenweider-Scherpenhuyzen, M. F. I., Bäbler, A., Vogel, H., & Hell, D. (1998) · NeuroReport · doi:10.1097/00001756-199812010-00024 · Cited by 1,018
Griffiths, R., Richards, W., Johnson, M., McCann, U., & Jesse, R. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881108094300 · Cited by 905
Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder
Moreno, F. A., Wiegand, C. B., Taitano, E. K., & Delgado, P. L. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n1110 · Cited by 789
Mithoefer, M. C., Wagner, M. T., Mithoefer, A. T., Jerome, L., & Doblin, R. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881110378371 · Cited by 674
Morgan, C. J. A., Curran, H. V., & the Independent Scientific Committee on Drugs (ISCD) (2012) · Addiction · doi:10.1111/j.1360-0443.2011.03576.x · Cited by 667
Cannabis in painful HIV-associated sensory neuropathy: A randomized placebo-controlled trial
Abrams, D. I., Jay, C. A., Shade, S. B., Vizoso, H., Reda, H., Press, S., Kelly, M. E., Rowbotham, M. C., & Petersen, K. L. (2007) · Neurology · doi:10.1212/01.wnl.0000253187.66183.9c · Cited by 598
Lysergic acid diethylamide (LSD) for alcoholism: meta-analysis of randomized controlled trials
Krebs, T. S., & Johansen, P.-Ø. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881112439253 · Cited by 583
The pharmacology of cannabinoid receptors and their ligands: an overview
Pertwee, R. G. (2006) · International Journal of Obesity · doi:10.1038/sj.ijo.0803272 · Cited by 557
Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment
Englund, A., Morrison, P. D., Nottage, J., Hague, D., Kane, F., Bonaccorso, S., Stone, J. M., Reichenberg, A., Brenneisen, R., Holt, D., et al. (2013) · Journal of Psychopharmacology · doi:10.1177/0269881112460109 · Cited by 462
Mithoefer, M. C., Wagner, M. T., Mithoefer, A. T., Jerome, L., Martin, S. F., Yazar-Klosinski, B., Michel, Y., Brewerton, T. D., & Doblin, R. (2013) · Journal of Psychopharmacology · doi:10.1177/0269881112456611 · Cited by 376
MUltiple Sclerosis and Extract of Cannabis: results of the MUSEC trial
Zajicek, J. P., Hobart, J. C., Slade, A., Barnes, D., Mattison, P. G., & on behalf of the MUSEC Research Group (2012) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-302468 · Cited by 278
Response of cluster headache to psilocybin and LSD
Sewell, R. A., Halpern, J. H., & Pope, H. G. (2006) · Neurology · doi:10.1212/01.wnl.0000219761.05466.43 · Cited by 259
Psychedelic Drugs Reconsidered
Seelye, E. E. (1980) · American Journal of Psychotherapy · doi:10.1176/appi.psychotherapy.1980.34.4.593 · Cited by 258
Functional Connectivity Measures After Psilocybin Inform a Novel Hypothesis of Early Psychosis
Carhart-Harris, R. L., Leech, R., Erritzoe, D., Williams, T. M., Stone, J. M., Evans, J., Sharp, D. J., Feilding, A., Wise, R. G., & Nutt, D. J. (2013) · Schizophrenia Bulletin · doi:10.1093/schbul/sbs117 · Cited by 256
Self-citationBedi, G., Hyman, D., & de Wit, H. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.08.003 · Cited by 247
Psychedelic Drugs Reconsidered
Grinspoon, L., & Bakalar, J. B. (1979) · Medical Entomology and Zoology · Cited by 239
Carhart-Harris, R. L., Leech, R., Williams, T. M., Erritzoe, D., Abbasi, N., Bargiotas, T., Hobden, P., Sharp, D. J., Evans, J., Feilding, A., et al. (2012) · British Journal of Psychiatry · doi:10.1192/bjp.bp.111.103309 · Cited by 237
Self-citationOpioid dependence treatment: options in pharmacotherapy
Stotts, A. L., Dodrill, C. L., & Kosten, T. R. (2009) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560903037168 · Cited by 222
Effects of MDMA on sociability and neural response to social threat and social reward
Bedi, G., Phan, K. L., Angstadt, M., & de Wit, H. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1635-z · Cited by 206
Acid Dreams: The Complete Social History of LSD: The CIA, the Sixties, and Beyond
Lee, M. A., & Shlain, B. (1985) · Cited by 206
Weber (2010) · Frontiers in Neuroscience · doi:10.3389/fnins.2010.00036 · Cited by 205
Morgan, C. J., Freeman, T. P., Schafer, G. L., & Curran, H. V. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.58 · Cited by 196
Can Drugs Be Used to Enhance the Psychotherapeutic Process?
Grinspoon, L., & Bakalar, J. B. (1986) · American Journal of Psychotherapy · doi:10.1176/appi.psychotherapy.1986.40.3.393 · Cited by 187
A Method of Conducting Therapeutic Sessions with MDMA
Greer, G. R., & Tolbert, R. (1998) · Journal of Psychoactive Drugs · doi:10.1080/02791072.1998.10399713 · Cited by 182
A review of the mechanisms involved in the acute MDMA (ecstasy)-induced hyperthermic response
Green, A. R., O'Shea, E., & Colado, M. I. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.07.006 · Cited by 181
Kiefer, R.-T., Rohr, P., Ploppa, A., Dieterich, H.-J., Grothusen, J., Koffler, S., Altemeyer, K.-H., Unertl, K., & Schwartzman, R. J. (2008) · Pain Medicine · doi:10.1111/j.1526-4637.2007.00402.x · Cited by 180
Cortical circuits for perceptual inference
Friston, K., & Kiebel, S. (2009) · Neural Networks · doi:10.1016/j.neunet.2009.07.023 · Cited by 172
Serotonergic regulation of neuronal excitability in the prefrontal cortex
Andrade, R. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.01.015 · Cited by 167
State of the Art Treatments for Cannabis Dependence
Danovitch, I., & Gorelick, D. A. (2012) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2012.03.003 · Cited by 129
ON THE THERAPEUTICAL USES AND TOXIC EFFECTS OF CANNABIS INDICA.
Reynolds, J. R. (1890) · The Lancet · doi:10.1016/s0140-6736(02)18723-x · Cited by 119
Passie, T., Emrich, H. M., Karst, M., Brandt, S. D., & Halpern, J. H. (2012) · Drug Testing and Analysis · doi:10.1002/dta.1377 · Cited by 117
Equasy — An overlooked addiction with implications for the current debate on drug harms
Nutt, D. (2009) · Journal of Psychopharmacology · doi:10.1177/0269881108099672 · Cited by 117
Self-citationKarst, M., Halpern, J. H., Bernateck, M., & Passie, T. (2010) · Cephalalgia · doi:10.1177/0333102410363490 · Cited by 106
Pertwee, R. G., Thomas, A., Stevenson, L. A., Ross, R. A., Varvel, S. A., Lichtman, A. H., Martin, B. R., & Razdan, R. K. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707124 · Cited by 105
Psychiatry, The Pharmaceutical Industry, and The Road to Better Therapeutics
Fibiger, H. C. (2012) · Schizophrenia Bulletin · doi:10.1093/schbul/sbs073 · Cited by 102
Enhancing Recovery after Stroke with Noradrenergic Pharmacotherapy: A New Frontier?
Gladstone, D. J., & Black, S. E. (2000) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100052173 · Cited by 89
Huot, P., Johnston, T. H., Lewis, K. D., Koprich, J. B., Reyes, M. G., Fox, S. H., Piggott, M., & Brotchie, J. M. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.1171-11.2011 · Cited by 85
Strassman, R. J. (1991) · Journal of Psychoactive Drugs · doi:10.1080/02791072.1991.10472572 · Cited by 47
Seizure Control as an Indicator of Therapeutic Usefulness
Wiebe, S. (2000) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100000743 · Cited by 40
Methoxetamine: from drug of abuse to rapid-acting antidepressant.
Coppola, M., & Mondola, R. (2012) · Medical Hypotheses · doi:10.1016/j.mehy.2012.07.002 · Cited by 38
The Varieties of Psychedelic Experience: The Classic Guide to the Effects of LSD on the Human Psyche
Masters, R., & Houston, J. (2000) · Medical Entomology and Zoology · Cited by 36
Edut, S., Rubovitch, V., Schreiber, S., & Pick, C. G. (2010) · Psychopharmacology · doi:10.1007/s00213-010-2098-y · Cited by 36
No. 7515. Single convention on Narcotic Drugs, 1961. Done at New York, on 30 March 1961
(1999) · United Nations Treaty Series · doi:10.18356/05857365-en-fr · Cited by 31
Cressey, D. (2011) · Nature · doi:10.1038/news.2011.367 · Cited by 30
An index of fatal toxicity for drugs of misuse
King, L. A., & Corkery, J. (2010) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.1090 · Cited by 28
Self-citationWeissenborn, R., & Nutt, D. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881111414751 · Cited by 18
Self-citationEl‐Mallakh, R. S., & Abraham, H. D. (2007) · Annals of Clinical Psychiatry · doi:10.1080/10401230601163592 · Cited by 17
Cannabis improves symptoms of ADHD
Strohbeck-Kuehner, P., Skopp, G., & Mattern, R. (2008) · Cited by 16
The neurobiology of addiction : new vistas
Robbins, T. W., Everitt, B. J., & Nutt, D. (2010) · Cited by 15
Self-citationUsing dopamine research to generate rational cannabinoid drug policy
Loewinger, G. C., Oleson, E. B., & Cheer, J. F. (2012) · Drug Testing and Analysis · doi:10.1002/dta.1410 · Cited by 13
Introduction. The neurobiology of drug addiction: new vistas
Robbins, T. W., Everitt, B. J., & Nutt, D. (2008) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2008.0108 · Cited by 13
Self-citation
Cited by
Carhart-Harris, R. L., Leech, R., Hellyer, P. J., Shanahan, M., Feilding, A., Tagliazucchi, E., Chialvo, D. R., & Nutt, D. (2014) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2014.00020 · Cited by 1,252
Pilot study of the 5-HT 2A R agonist psilocybin in the treatment of tobacco addiction
Johnson, M. W., Garcia-Romeu, A., Cosimano, M. P., & Griffiths, R. R. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881114548296 · Cited by 914
“Despite suggestive findings, this line of investigation was abandoned due to controversy surrounding the recreational use of hallucinogens and regulatory restrictions impeding subsequent research with 5-HT2AR agonists (Mangini, 1998; Nutt et al., 2013).”
BackgroundThe entropic brain - revisited
Carhart-Harris, R. L. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.03.010 · Cited by 522
Johnson, M. W., Hendricks, P. S., Barrett, F. S., & Griffiths, R. R. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.11.010 · Cited by 506
Psilocybin-Occasioned mystical experiences in the treatment of tobacco addiction.
Garcia-Romeu, A., Griffiths, R., & Johnson, M. (2015) · Current Drug Abuse Reviews · doi:10.2174/1874473708666150107121331 · Cited by 476
Metadata
- Authors
- Nutt, D. J., King, L. A., & Nichols, D. E.
- Venue
- Nature Reviews Neuroscience
- Published
- 2013-06-12
- Volume
- 14
- Issue
- 8
- Pages
- 577-585
- ISSN
- 1471-003X (ISSN-L)
- 1471-0048
- OpenAlex
- W2087848624
- Cited by
- 337
- References
- 60
- FWCI
- 4.84
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.